Melanoma awareness campaign to protect tradies
Promoting skin cancer awareness amongst Victorian construction workers is the focus of a new initiative that was launched at the site of the new Paula Fox Melanoma and Cancer Centre today.
Visitor information – Everything you need to know about visiting our sites.
Promoting skin cancer awareness amongst Victorian construction workers is the focus of a new initiative that was launched at the site of the new Paula Fox Melanoma and Cancer Centre today.
In a possible breakthrough for the early detection and diagnosis of skin cancer, Victorian researchers are testing how artificial intelligence (AI) can become a powerful and readily accessible tool for dermatologists.
Biological differences between men and women can have an impact on the success of melanoma treatment, according to new research co-led by Alfred oncologist Miles Andrews.
A new resource provided to patients at the time of their advanced melanoma diagnosis is set to make things easier during what can be an overwhelming time.
Cancer care for Australians is set to be transformed as building starts on the Paula Fox Melanoma and Cancer Centre at The Alfred.
Did you know that more than half of our 300 open trials are cancer-related trials?
Our cancer clinical trials have allowed us to put new and cutting-edge treatment into clinical practice. They have also enabled us to recruit highly-engaged staff who are always looking to improve the way we deliver care.
Victorians at risk of melanoma now have access to cutting-edge 3D whole body imaging, which promises to improve detection and management of the deadly cancer.
This year, the Victorian Melanoma Service (VMS) at The Alfred has seen a significant drop in referrals. But cases of melanoma have not dropped – prompting specialists to urge all Victorians to act now before it’s too late.
Artificial intelligence (AI) could soon become a powerful tool in skin cancer assessment. The Victorian Melanoma Service is currently conducting a trial into the effectiveness of the technology.
Australians will soon have greater access to potentially lifesaving treatments for rare cancers and other diseases with the establishment of a clinical trials network led by Alfred Health and Monash University.